| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/24/2022 | Marker Therapeutics, Inc. | MRKR | Payment of Exercise | Common Stock | 48.4k | $0.48 | $23.5k | | 03/24/2022 |
| 03/24/2022 | Marker Therapeutics, Inc. | MRKR | Grant | Common Stock | 199.1k | $0.00 | $0 | | 03/24/2022 |
| 02/17/2022 | Marker Therapeutics, Inc. | MRKR | Grant | Employee Stock Option (right to buy) | 430k | $0.46 | $197.8k | | 02/17/2022 |
| 03/16/2021 | Marker Therapeutics, Inc. | MRKR | Purchase | Common Stock | 142.9k | $1.75 | $250k | | 03/16/2021 |
| 02/11/2021 | Marker Therapeutics, Inc. | MRKR | Grant | Employee Stock Option (right to buy) | 430k | $3.06 | $1.3M | | 02/11/2021 |
| 03/10/2020 | Marker Therapeutics, Inc. | MRKR | Grant | Employee Stock Option (Right to Buy) | 388.8k | $2.12 | $824.3k | | 03/10/2020 |
| 03/10/2020 | Marker Therapeutics, Inc. | MRKR | Grant | Employee Stock Option (Right to Buy) | 41.2k | $2.12 | $87.3k | | 03/10/2020 |
| 08/14/2019 | Marker Therapeutics, Inc. | MRKR | Purchase | Common Stock | 10k | $4.62 | $46.2k | | 08/14/2019 |
| 10/19/2018 | Marker Therapeutics, Inc. | MRKR | Grant | | 200k | $9.18 | $1.8M | By Wife | 10/19/2018 |
| 10/19/2018 | Marker Therapeutics, Inc. | MRKR | Grant | | 1.4M | $9.18 | $12.5M | | 10/19/2018 |
| 01/03/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Restricted Stock Units | 6.2k | $0.00 | $0 | | 01/03/2017 |
| 01/03/2017 | BELLICUM PHARMACEUTICALS, INC | BLCM | Grant | Employee Stock Option (right to buy) | 11.2k | $13.89 | $156.3k | | 01/03/2017 |